Artelo Biosciences logo
Artelo Biosciences ARTL
$ 7.01 -3.82%

Annual report 2025
added 02-24-2026

report update icon

Artelo Biosciences Long Term Debt Current 2011-2026 | ARTL

Annual Long Term Debt Current Artelo Biosciences

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
40 K 35 K 23 K 40 K 31 K - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
40 K 23 K 33.8 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Amgen Amgen
AMGN
135 M $ 345.02 1.52 % $ 186 B usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
6.76 M $ 12.59 2.19 % $ 3.95 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
argenx SE argenx SE
ARGX
10.8 M $ 777.72 1.61 % $ 25 B niderlandNiderland
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 23.65 1.63 % $ 3.01 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.43 4.78 % $ 381 M britainBritain
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.86 2.74 % $ 9.29 B australiaAustralia
BioNTech SE BioNTech SE
BNTX
45 M $ 91.14 1.7 % $ 27.2 B germanyGermany
CymaBay Therapeutics CymaBay Therapeutics
CBAY
7 K - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.66 3.5 % $ 16.7 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
1.35 M - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
1.38 M - - $ 1.41 B usaUSA
Cabaletta Bio Cabaletta Bio
CABA
3.46 M $ 3.1 0.97 % $ 311 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 3.03 - $ 6.59 B israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Cerus Corporation Cerus Corporation
CERS
2.9 M $ 1.95 5.99 % $ 372 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
1.16 M - - $ 401 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
100 K $ 2.8 1.82 % $ 7.3 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
781 K - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
3.5 M - - $ 2.18 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
4.18 M - - $ 2.02 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
1.63 M $ 9.61 -1.06 % $ 128 M usaUSA